Researchers in Australia report that brain plaques may manifest later than other indicators of Alzheimer's disease, such as behavioral changes, brain inflammation, nerve cell loss and subtle memory loss. The finding suggests that Alzheimer's tests targeting plaques may not catch the disease in its earlier stages, according to the study published in the journal PLOS ONE. The study also indicates that brain inflammation and cell loss may have potential as alternative targets for therapy, a researcher said.

Related Summaries